TGF-β in kidney fibrosis: A target for gene therapy

Border, 1992, Transforming growth factor-β in disease: The dark side of tissue repair, J Clin Invest, 90, 1, 10.1172/JCI115821 Border, 1994, Transforming growth factor-β in tissue fibrosis, N Engl J Med, 331, 1286, 10.1056/NEJM199411103311907 Sporn, 1992, Transforming growth factor-β: Recent progress and new challenges, J Cell Biol, 119, 1017, 10.1083/jcb.119.5.1017 Roberts, 1989, Peptide growth factors and their receptors, 419 Okuda, 1990, Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis, J Clin Invest, 86, 453, 10.1172/JCI114731 Bagchus, 1986, Glomerulonephritis induced by monoclonal anti-thy 1.1 antibodies. A sequential histological and ultrastructural study in the rat, Lab Invest, 55, 680 Yamamoto, 1987, Quantitative and qualitative studies of antibody-induced mesangial cell damage in the rat, Kidney Int, 32, 514, 10.1038/ki.1987.240 Roberts, 1992, Differential expression of the TGF-β isoforms in embryogenesis suggests specific roles in developing and adult tissues, Mol Repro Dev, 32, 91, 10.1002/mrd.1080320203 Nakamura, 1992, Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-β, Kidney Int, 41, 1213, 10.1038/ki.1992.183 Border, 1990, Transforming growth factor-β regulates production of proteoglycans by mesangial cells, Kidney Int, 37, 689, 10.1038/ki.1990.35 Baricos, 1995, ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade, Kidney Int, 47, 1039, 10.1038/ki.1995.150 Tomooka, 1992, Glomerular matrix accumulation is linked to inhibition of the plasmin protease system, Kidney Int, 42, 1462, 10.1038/ki.1992.442 Kagami, 1993, Coordinated expression of β1 integrins and transforming growth factor-β-induced matrix proteins in glomerulonephritis, Lab Invest, 69, 68 Terrell, 1993, Pathology of recombinant human transforming growth factor-β in rats and rabbits, Int Rev Exp Pathol, 34, 43, 10.1016/B978-0-12-364935-5.50009-2 Isaka, 1993, Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet-derived growth factor gene into the rat kidney, J Clin Invest, 92, 2597, 10.1172/JCI116874 Kopp, 1996, Transgenic mice with increased plasma levels of TGF-β1 develop progressive renal disease, Lab Invest, 74, 991 Roberts, 1990, Transforming growth factor-beta (TGF-β): A multifunctional effector of both soft and hard tissue regeneration, 89 Ogawa, 1991, Differences in the biological activities of transforming growth factor-β and platelet-derived growth factor in vivo, Growth Factors, 5, 57, 10.3109/08977199109000271 Yamamoto, 1994, Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis, Kidney Int, 45, 916, 10.1038/ki.1994.122 Yamamoto, 1993, Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy, Proc Natl Acad Sci USA, 90, 1814, 10.1073/pnas.90.5.1814 Sharma, 1995, Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-β as a key mediator, Diabetes, 44, 1139, 10.2337/diab.44.10.1139 Border, 1996, Transforming growth factor in diabetic nephropathy, Diabetes Metabol Rev, 12, 309, 10.1002/(SICI)1099-0895(199612)12:4<309::AID-DMR171>3.0.CO;2-A Yamamoto, 1996, Expression of transforming growth factor-β isoforms in human glomerular diseases, Kidney Int, 49, 461, 10.1038/ki.1996.65 Shihab, 1995, Transforming growth factor-β and matrix protein expression in acute and chronic rejection of human renal allografts, J Am Soc Nephrol, 6, 10.1681/ASN.V62286 Peten, 1992, The contribution of increased collagen synthesis to human glomerulosclerosis: A quantative analysis of α2(IV) collagen mRNA expression by competitive polymerase chain reaction, J Exp Med, 176, 1571, 10.1084/jem.176.6.1571 Shihab, 1996, Role of transforming growth factor-β1 in experimental chronic cyclosporine nephropathy, Kidney Int, 49, 1141, 10.1038/ki.1996.165 Border, 1990, Suppression of experimental glomerulonephritis by anti serum against transforming growth factor β1, Nature, 346, 371, 10.1038/346371a0 Shah, 1992, Control of scarring in adult wounds by neutralizing antibody to transforming growth factor β, Lancet, 339, 213, 10.1016/0140-6736(92)90009-R Ruoslahti, 1991, Proteoglycans as modulators of growth factor activities, Cell, 64, 867, 10.1016/0092-8674(91)90308-L Hildebrand, 1994, Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor β, Biochem J, 302, 527, 10.1042/bj3020527 Kähäris, 1991, Differential regulation of extracellular matrix proteoglycan (PG) gene expression, J Biol Chem, 266, 10608 Brees, 1994, Deficiency of the TGF-β antagonist, decorin, precedes matrix deposition in experimental glomerulonephritis, J Am Soc Nephrol, 5, 801 Westergren-Thorsson, 1993, Altered expression of small proteoglycans, collagen, and transforming growth factor-β, in developing bleomycin-induced pulmonary fibrosis in rats, J Clin Invest, 92, 632, 10.1172/JCI116631 Border, 1992, Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease, Nature, 360, 361, 10.1038/360361a0 Wolff, 1990, Direct gene transfer into mouse muscle in vivo, Science, 247, 1465, 10.1126/science.1690918 Blau, 1995, Gene therapy—A novel form of drug delivery, N Engl J Med, 333, 1465, 10.1056/NEJM199511023331808 Blau, 1995, Muscle-mediated gene therapy, N Engl J Med, 333, 1204, 10.1056/NEJM199511023331808 Danko, 1994, Direct gene transfer into muscle, Vaccine, 12, 1499, 10.1016/0264-410X(94)90072-8 Isaka, 1996, Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney, Nature Med, 2, 418, 10.1038/nm0496-418 Noble, 1992, In vivo interactions of TGF-β and extracellular matrix, Progr Growth Factor Res, 4, 369, 10.1016/0955-2235(92)90017-C